Clik here to view.
The Momentum of CDMOs: What to Look Out for When Choosing a Drug Development...
In recent years, the biopharma industry has experienced a shift in the way companies organize their drug development and manufacturing processes. Whereas many biopharma companies worked with Contract...
View ArticleClik here to view.
Meet the World’s First Biotech Manufacturing Organization, BMO
CRO, CMO, CDMO. These acronyms are well known in the biotech and pharma industry. But what is a BMO? If you haven’t heard of it, don’t worry. After all, there is only one BMO worldwide. We have set out...
View ArticleClik here to view.
How Can Small Biotechs Use CROs to Apply the 5R’s Concept?
Although the exact percentage of drugs failing clinical trials is still widely disputed, the fact remains that the number of compounds successfully passing clinical trials is persistently slim. The...
View ArticleClik here to view.
Infographic: How to Increase the Success of Drug Development with Smart Design?
Although failure rates in drug development are still quite high, a lot can be done to mitigate the risk. This brand new infographic shows how smart design can increase the chance of success for drug...
View ArticleClik here to view.
Why European Biotechs Are Heading to Asia for Their Clinical Trials
As the region with the fastest-growing clinical activity, Asia is becoming increasingly attractive to European and North American biotechs. This progress in clinical trial activity is the result of a...
View ArticleClik here to view.
How Can Emerging Biotechs Ensure Their Collaboration with CROs is Successful?
As the complexity of drug discovery and development steadily increases, so do the costs. With average expenditures for prescription drug R&D ranging between $2.5 and $3 billion, small and...
View ArticleClik here to view.
Five Challenges For Life Science Marketers in 2020
Developing a new drug has an estimated cost of €583M to €2.4B. Much of this spending goes towards companies, such as vendors, CROs, and CDMOs, who generate value by commercializing and industrializing...
View ArticleClik here to view.
Exploring the Evolving Role of CDMOs
In 2019, the global contract development and manufacturing organizations (CDMO) market was valued at about €139.9B ($151B). By 2025, it is estimated to reach a staggering €228B ($246B). The growing...
View ArticleClik here to view.
Why Biotechs Should Invest in Good Outsourcing Management of CROs
The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs is seen as a standard in the drug development industry. However, the...
View Article
